← SearchTHERAPEUTIC EFFECTS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA AGONIST ON COMBAT-INDUCED PROLIFERATIVE VITREORETINOPATH$267,544FY2025Defense Health AgencyDODMetis Foundation, San Antonio TXInvestigatorsView source on USAspending →